As part of its continued international growth strategy, Glycorex Transplantation AB (publ) has entered into a distribution agreement with Buenos Aires-based Stone Fly Salud SA for the rights to Glycosorb® ABO (CE-marked) in Argentina.
Stone Fly Salud SA specializes in the distribution of pharmaceuticals and medical products, having operated in the Argentine market since 2006. The company works closely with local healthcare providers to supply critical medical technologies across the region.
The agreement opens a significant market opportunity for Glycorex, as Argentina performs approximately 1,600 kidney transplants annually across more than 60 specialized centers.
"We are pleased to finalize this agreement and look forward to working alongside the Stone Fly Salud team," says Carl Magnus Schultz CEO at Glycorex Transplantation. "Together, we will make Glycosorb® ABO products accessible for ABO-incompatible transplantations and transfusion medicine applications throughout Argentina."